These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 12619108

  • 21. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers.
    Gao WM, Romkes M, Siegfried JM, Luketich JD, Keohavong P.
    Mol Carcinog; 2006 Nov; 45(11):828-32. PubMed ID: 16865671
    [Abstract] [Full Text] [Related]

  • 22. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors.
    Bumroongkit K, Rannala B, Traisathit P, Srikummool M, Wongchai Y, Kangwanpong D.
    Cancer Genet Cytogenet; 2008 Aug; 185(1):20-7. PubMed ID: 18656689
    [Abstract] [Full Text] [Related]

  • 23. Polymorphisms in XPD and TP53 and mutation in human lung cancer.
    Mechanic LE, Marrogi AJ, Welsh JA, Bowman ED, Khan MA, Enewold L, Zheng YL, Chanock S, Shields PG, Harris CC.
    Carcinogenesis; 2005 Mar; 26(3):597-604. PubMed ID: 15564288
    [Abstract] [Full Text] [Related]

  • 24. [Lung cancer in smokers and never-smokers].
    Helland A, Brustugun OT.
    Tidsskr Nor Laegeforen; 2009 Sep 24; 129(18):1859-62. PubMed ID: 19844277
    [Abstract] [Full Text] [Related]

  • 25. Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.
    Pulling LC, Divine KK, Klinge DM, Gilliland FD, Kang T, Schwartz AG, Bocklage TJ, Belinsky SA.
    Cancer Res; 2003 Aug 15; 63(16):4842-8. PubMed ID: 12941804
    [Abstract] [Full Text] [Related]

  • 26. [TP53 mutations and molecular epidemiology].
    Otsuka K, Ishioka C.
    Gan To Kagaku Ryoho; 2007 May 15; 34(5):683-9. PubMed ID: 17496437
    [Abstract] [Full Text] [Related]

  • 27. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
    Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M.
    Hum Mutat; 2007 Jun 15; 28(6):622-9. PubMed ID: 17311302
    [Abstract] [Full Text] [Related]

  • 28. Smoking and cancer-related gene expression in bronchial epithelium and non-small-cell lung cancers.
    Woenckhaus M, Klein-Hitpass L, Grepmeier U, Merk J, Pfeifer M, Wild P, Bettstetter M, Wuensch P, Blaszyk H, Hartmann A, Hofstaedter F, Dietmaier W.
    J Pathol; 2006 Oct 15; 210(2):192-204. PubMed ID: 16915569
    [Abstract] [Full Text] [Related]

  • 29. Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism.
    Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J.
    Lung Cancer; 2006 Apr 15; 52(1):9-14. PubMed ID: 16499995
    [Abstract] [Full Text] [Related]

  • 30. Cigarette smoking and KRAS oncogene mutations in sporadic colorectal cancer: results from the Netherlands Cohort Study.
    Weijenberg MP, Aardening PW, de Kok TM, de Goeij AF, van den Brandt PA.
    Mutat Res; 2008 Mar 29; 652(1):54-64. PubMed ID: 18296105
    [Abstract] [Full Text] [Related]

  • 31. Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.
    Toyooka S, Tokumo M, Shigematsu H, Matsuo K, Asano H, Tomii K, Ichihara S, Suzuki M, Aoe M, Date H, Gazdar AF, Shimizu N.
    Cancer Res; 2006 Feb 01; 66(3):1371-5. PubMed ID: 16452191
    [Abstract] [Full Text] [Related]

  • 32. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ, Hasegawa M, Hirao T, Kim DH, Aldape K, Hinds PW, Wiencke JK, Nelson HH, Kelsey KT.
    Cancer Res; 2004 Dec 01; 64(23):8702-7. PubMed ID: 15574780
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Alterations of 9p in squamous cell carcinoma and adenocarcinoma of the lung: association with smoking, TP53, and survival.
    Marsit CJ, Wiencke JK, Nelson HH, Kim DH, Hinds PW, Aldape K, Kelsey KT.
    Cancer Genet Cytogenet; 2005 Oct 15; 162(2):115-21. PubMed ID: 16213358
    [Abstract] [Full Text] [Related]

  • 35. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
    Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY.
    Cancer Genet Cytogenet; 2007 Mar 15; 173(2):107-13. PubMed ID: 17321325
    [Abstract] [Full Text] [Related]

  • 36. In silico p53 mutation hotspots in lung cancer.
    Lewis PD, Parry JM.
    Carcinogenesis; 2004 Jul 15; 25(7):1099-107. PubMed ID: 14729588
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.
    Petitjean A, Achatz MI, Borresen-Dale AL, Hainaut P, Olivier M.
    Oncogene; 2007 Apr 02; 26(15):2157-65. PubMed ID: 17401424
    [Abstract] [Full Text] [Related]

  • 39. Aberrant methylation of the FHIT gene in chronic smokers with early stage squamous cell carcinoma of the lung.
    Kim JS, Kim H, Shim YM, Han J, Park J, Kim DH.
    Carcinogenesis; 2004 Nov 02; 25(11):2165-71. PubMed ID: 15231689
    [Abstract] [Full Text] [Related]

  • 40. TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America.
    Szymańska K, Levi JE, Menezes A, Wünsch-Filho V, Eluf-Neto J, Koifman S, Matos E, Daudt AW, Curado MP, Villar S, Pawlita M, Waterboer T, Boffetta P, Hainaut P, Brennan P.
    Carcinogenesis; 2010 Jun 02; 31(6):1054-9. PubMed ID: 19955396
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.